A facile automated multiple-well platform of immunized tumor organoid cultures in ECM-mimicked hydrogels for chem-immunotherapy evaluation

Abstract

Breast cancer often develops drug resistance during chemotherapy, and immunotherapeutic agents always exhibit ineffectiveness when used as a single treatment; thus, it is necessary to develop a chemo-immunotherapy strategy in clinics. However, there is still a challenge to evaluate the chemo-immunotherapy efficacy by conventional 2D cell culture and animal models. In this study, we developed a facile automated multiple-well platform for fabricating tumor associated macrophages (TAMs)-immunized breast cancer organoids in alginate hydrogels. An automated robotic microinjection system was used for building alginate hydrogels in situ and seeding mixed cell suspensions of breast cancer cells and TAMs into hydrogels to form organoids. The induced drug resistance to epirubicin was observed in breast cancer organoids with TAMs, but it could be inhibited by targeted immunotherapy PLX3397. The synergistic effects were also evaluated in several co-administration strategies of PLX3397 in combination with epirubicin. The RNA-seq and quantitative polymerase chain reaction were further used to examine gene transcription levels in the co-administration and find out three genes (IL6, CD37, and GLS2) with significant differences, which were involved in the tumor necrosis factor signaling, PI3K-Akt signaling and epidermal growth factor receptor tyrosine kinase inhibitor resistance pathway. The results demonstrated that the automated multiple-well platform showed the potential to replace the conventional bulk culture method in evaluating the therapeutic effects of chem-immunotherapy.

Keywords

breast cancer / chem-immunotherapy / hydrogels / immunized tumor organoids / tumor associated macrophages

References

[1] P. Wilcock, R. M. Webster, Nat. Rev. Drug Discov. 2021, 20, 339.

[2] U. Mehraj, A. H. Dar, N. A. Wani, M. A. Mir, Cancer Chemother. Pharmacol. 2021, 87, 147.

[3] M. Khasraw, R. Bell, C. Dang, Breast 2012, 21, 142.

[4] Y. T. Xie, H. Yang, C. Yang, L. R. He, X. Zhang, L. Peng, H. B. Zhu, L. Gao, Front. Oncol. 2022, 12, 933666.

[5] L. B. Kennedy, A. K. S. Salama, CA Cancer J. Clin. 2020, 70, 86.

[6] M. Vanneman, G. Dranoff, Nat. Rev. Cancer 2012, 12, 237.

[7] V. Debien, A. De Caluwe, X. X. Wang, M. Piccart-Gebhart, V. K. Tuohy, E. Romano, L. Buisseret, NPJ Breast Cancer 2023, 9, 7.

[8] Y. N. Lamb, Drugs 2019, 79, 1805.

[9] Z. H. Zhao, S. R. Zhang, N. Jiang, W. J. Zhu, D. F. Song, S. Y. Liu, W. H. Yu, Y. H. Bai, Y. L. Zhang, X. Y. Wang, X. M. Zhong, H. Q. Guo, Z. J. Guo, R. Yang, J. P. Li, Angew. Chem. Int. Ed. 2024, 63, 63.

[10] N. E. Sharpless, R. A. DePinho, Nat. Rev. Drug Discov. 2006, 5, 741.

[11] J. Drost, H. Clevers, Nat. Rev. Cancer 2018, 18, 407.

[12] S. Y. Yin, R. B. Xi, A. W. Wu, S. Wang, Y. J. Li, C. B. Wang, L. Tang, Y. C. Xia, D. Yang, J. Li, B. Q. Ye, Y. Yu, J. Y. Wang, H. S. Zhang, F. Ren, Y. Y. Zhang, D. H. Shen, L. Wang, X. J. Ying, Z. W. Li, Z. D. Bu, X. Ji, X. Y. Gao, Y. N. Jia, Z. Y. Jia, N. Li, Z. Y. Li, J. F. Ji, J. Z. J. Xi, Sci. Transl. Med. 2020, 12, eaaz1723.

[13] H. X. Xu, D. C. Jiao, A. G. Liu, K. M. Wu, J. Hematol. Oncol. 2022, 15, 58.

[14] N. Sachs, J. de Ligt, O. Kopper, E. Gogola, G. Bounova, F. Weeber, A. V. Balgobind, K. Wind, A. Gracanin, H. Begthel, J. Korving, R. van Boxtel, A. A. Duarte, D. Lelieveld, A. van Hoeck, R. F. Ernst, F. Blokzijl, I. J. Nijman, M. Hoogstraat, M. van de Ven, D. A. Egan, V. Zinzalla, J. Moll, S. F. Boj, E. E. Voest, L. Wessels, P. J. van Diest, S. Rottenberg, R. G. J. Vries, E. Cuppen, H. Clevers, Cell 2018, 172, 373.

[15] D. D. Guan, X. Z. Liu, Q. Y. Shi, B. J. He, C. P. Zheng, X. L. Meng, World J. Surg. Oncol. 2023, 21, 343.

[16] K. Yuki, N. Cheng, M. Nakano, C. J. Kuo, Trends Immunol. 2020, 41, 652.

[17] L. Wakefield, S. Agarwal, K. Tanner, Cell 2023, 186, 1792.

[18] I. Vitale, G. Manic, L. M. Coussens, G. Kroemer, L. Galluzzi, Cell Metab. 2019, 30, 36.

[19] Z. Z. Liu, N. Y. Xu, M. L. Wang, R. Z. Tang, X. Q. Liu, Biomater. Sci. 2022, 10, 2315.

[20] N. Y. Xu, J. Li, M. L. Wang, X. Y. Chen, R. Z. Tang, X. Q. Liu, ACS Appl. Mater. Interfaces 2024, 16, 11275.

[21] A. Memic, T. Colombani, L. J. Eggermont, M. Rezaeeyazdi, J. Steingold, Z. J. Rogers, K. J. Navare, H. S. Mohammed, S. A. Bencherif, Adv. Therap. 2019, 2, 1800114.

[22] H. Omidian, S. D. Chowdhury, N. Babanejad, Pharmaceutics 2023, 15, 1836.

[23] S. J. Wang, J. R. Wang, Z. Q. Chen, J. M. Luo, W. Guo, L. L. Sun, L. Z. Lin, npj Precis. Oncol. 2024, 8, 31.

[24] C. X. Yang, L. Y. He, P. Q. He, Y. W. Liu, W. J. Wang, Y. Q. He, Y. Du, F. Gao, Med. Oncol. 2015, 32, 14.

[25] C. Wei, C. G. Yang, S. Y. Wang, D. D. Shi, C. X. Zhang, X. B. Lin, B. Xiong, OncoTargets Ther. 2019, 12, 3051.

[26] K. C. Wheeler, M. K. Jena, B. S. Pradhan, N. Nayak, S. Das, C. D. Hsu, D. S. Wheeler, K. Chen, N. R. Nayak, PLoS One 2018, 13, e0191040.

[27] Y. T. Sun, Y. T. Dong, X. J. Liu, Y. D. Zhang, H. Bai, J. C. Duan, Z. H. Tian, X. Yan, J. Wang, Z. J. Wang, EBioMedicine 2022, 83, 104200.

[28] N. Kumari, B. S. Dwarakanath, A. Das, A. N. Bhatt, Tumor Biol. 2016, 37, 11553.

[29] X. J. Yan, Q. W. Zhou, H. C. Zhu, W. D. Liu, H. J. Xu, W. Yin, M. Zhao, X. J. Jiang, C. P. Ren, iScience 2021, 24, 103249.

[30] B. J. Altman, Z. E. Stine, C. V. Dang, Nat. Rev. Cancer 2016, 16, 619.

[31] M. Faruk Prihantono, Ann. Med. Surg. 2021, 70, 102793.

[32] N. Vasan, J. Baselga, D. M. Hyman, Nature 2019, 575, 299.

[33] Z. N. Yuan, Y. P. Li, S. F. Zhang, X. Y. Wang, H. Dou, X. Yu, Z. R. Zhang, S. S. Yang, M. Xiao, Mol. Cancer 2023, 22, 48.

[34] B. A. Kidd, A. Wroblewska, M. R. Boland, J. Agudo, M. Merad, N. P. Tatonetti, B. D. Brown, J. T. Dudley, Nat. Biotechnol. 2016, 34, 47.

[35] S. Kim, S. Min, Y. S. Choi, S. H. Jo, J. H. Jung, K. Han, J. Kim, S. An, Y. W. Ji, Y. G. Kim, S. W. Cho, Nat. Commun. 2022, 13, 1692.

[36] W. Bonani, N. Cagol, D. Maniglio, in Biomimicked Biomaterials, Vol. 1250 (Eds: H. Chun, R. Reis, A. Motta, G. Khang), Springer, Singapore 2020, pp. 49–61.

[37] Z. L. Zhou, K. Van der Jeught, Y. J. Li, S. Sharma, T. Yu, I. Moulana, S. Liu, J. Wan, P. R. Territo, M. Opyrchal, X. N. Zhang, G. H. Wan, X. B. Lu, Adv. Sci. 2023, 10, 2300548.

[38] N. Brandenberg, S. Hoehnel, F. Kuttler, K. Homicsko, C. Ceroni, T. Ringel, N. Gjorevski, G. Schwank, G. Coukos, G. Turcatti, M. P. Lutolf, Nat. Biomed. Eng. 2020, 4, 863.

[39] P. Kakni, R. Hueber, K. Knoops, C. López-Iglesias, R. Truckenmüller, P. Habibovic, S. Giselbrecht, Adv. Biosys. 2020, 4, 2000126.

[40] H. S. Shin, H. J. Hong, W. G. Koh, J. Y. Lim, ACS Biomater. Sci. Eng. 2018, 4, 4311.

[41] S. A. Yi, Y. X. Zhang, C. Rathnam, T. Pongkulapa, K. B. Lee, Adv. Mater. 2021, 33, 2007949.

[42] A. Stern, B. Thompson, K. Williams, R. McClellan, S. Gebhart, J. Hartman, Slas Discov. 2022, 27, 201.

[43] A. Beghin, G. Grenci, G. Sahni, S. Guo, H. Rajendiran, T. Delaire, S. B. M. Raffi, D. Blanc, R. de Mets, H. T. Ong, X. Galindo, A. Monet, V. Acharya, V. Racine, F. Levet, R. Galland, J. B. Sibarita, V. Viasnoff, Nat. Methods 2022, 19, 881.

[44] S. Giger, M. Hofer, M. Miljkovic-Licina, S. Hoehnel, N. Brandenberg, R. Guiet, M. Ehrbar, E. Kleiner, K. Gegenschatz-Schmid, T. Matthes, M. P. Lutolf, APL Bioeng. 2022, 6, 036101.

[45] Y. S. Wu, K. Y. Li, Y. Q. Li, T. Sun, C. Liu, C. H. Dong, T. Zhao, D. C. Tang, X. J. Chen, X. F. Chen, P. Liu, Nucleic Acids Res. 2022, 50, e28.

[46] Nat. Cancer 2020, 1, 1.

[47] A. Skirzynska, C. Xue, M. S. Shoichet, Adv. Mater. 2024, 36, 2310637.

[48] W. D. Tap, Z. A. Wainberg, S. P. Anthony, P. N. Ibrahim, C. Zhang, J. H. Healey, B. Chmielowski, A. P. Staddon, A. L. Cohn, G. I. Shapiro, V. L. Keedy, A. S. Singh, I. Puzanov, E. L. Kwak, A. J. Wagner, D. D. Von Hoff, G. J. Weiss, R. K. Ramanathan, J. Zhang, G. Habets, Y. Zhang, E. A. Burton, G. Visor, L. Sanftner, P. Severson, H. Nguyen, M. J. Kim, A. Marimuthu, G. Tsang, R. Shellooe, C. Gee, B. L. West, P. Hirth, K. Nolop, M. van de Rijn, H. H. Hsu, C. Peterfy, P. S. Lin, S. Tong-Starksen, G. Bollag, N. Engl. J. Med. 2015, 373, 428.

[49] W. D. Tap, H. Gelderblom, E. Palmerini, J. Desai, S. Bauer, J. Y. Blay, T. Alcindor, K. Ganjoo, J. Martín-Broto, C. W. Ryan, D. M. Thomas, C. Peterfy, J. H. Healey, M. van de Sande, H. L. Gelhorn, D. E. Shuster, Q. Wang, A. Yver, H. H. Hsu, P. S. Lin, S. Tong-Starksen, S. Stacchiotti, A. J. Wagner, E. Investigators, Lancet 2019, 394, 478.

[50] D. Yan, J. Kowal, L. Akkari, A. J. Schuhmacher, J. T. Huse, B. L. West, J. A. Joyce, Oncogene 2017, 36, 6049.

[51] T. Fujiwara, M. A. Yakoub, A. Chandler, A. B. Christ, G. L. Yang, O. Ouerfelli, V. K. Rajasekhar, A. Yoshida, H. Kondo, T. Hata, H. Tazawa, Y. Dogan, M. A. S. Moore, T. Fujiwara, T. Ozaki, E. Purdue, J. H. Healey, Mol. Cancer Ther. 2021, 20, 1388.

[52] X. N. Xiang, J. G. Wang, D. Lu, X. Xu, Signal Transduct. Targeted Ther. 2021, 6, 75.

[53] J. H. Rannikko, M. Hollmén, Br. J. Cancer 2024, 131, 627.

[54] W. L. Liu, M. Yalcinkaya, I. F. Maestre, M. Olszewska, P. B. Ampomah, J. B. Heimlich, R. R. Wang, P. S. Vela, T. Xiao, A. G. Bick, R. Levine, E. P. Papapetrou, P. Libby, I. Tabas, N. Wang, A. R. Tall, Nat. Cardiovasc. Res. 2023, 2, 572.

[55] E. H. Bent, L. R. Millán-Barea, I. Zhuang, D. R. Goulet, J. Fröse, M. T. Hemann, Nat. Commun. 2021, 12, 6218.

[56] R. Lapalombella, Y. Y. Yeh, L. W. Wang, A. Ramanunni, S. Rafiq, S. Jha, J. Staubli, D. M. Lucas, R. Mani, S. E. M. Herman, A. J. Johnson, A. Lozanski, L. Andritsos, J. Jones, J. M. Flynn, B. Lannutti, P. Thompson, P. Algate, S. Stromatt, D. Jarjoura, X. K. Mo, D. S. Wang, C. S. Chen, G. Lozanski, N. A. Heerema, S. Tridandapani, M. A. Freitas, N. Muthusamy, J. C. Byrd, Cancer Cell 2012, 21, 694.

[57] M. J. Lukey, A. A. Cluntun, W. P. Katt, M. C. J. Lin, J. E. Druso, S. Ramachandran, J. W. Erickson, H. H. Le, Z. E. Wang, B. Blank, K. S. Greene, R. A. Cerione, Cell Rep. 2019, 29, 76.

[58] S. K. Saha, S. M. R. Islam, M. Abdullah-AL-Wadud, S. Islam, F. Ali, K. S. Park, J. Clin. Med. 2019, 8, 355.

[59] M. M. Dias, D. Adamoski, L. M. dos Reis, C. F. R. Ascençao, K. R. S. de Oliveira, A. C. P. Mafra, A. C. D. Bastos, M. Quintero, C. D. Cassago, I. M. Ferreira, C. H. V. Fidelis, S. A. Rocco, M. C. Bajgelman, Z. Stine, I. Berindan-Neagoe, G. A. Calin, A. L. B. Ambrosio, S. M. G. Dias, Oncogene 2020, 39, 690.

[60] L. S. Xiang, G. F. Xie, C. Liu, J. Zhou, J. F. Chen, S. T. Yu, J. J. Li, X. L. Pang, H. Shi, H. J. Liang, Biochim. Biophys. Acta, Mol. Cell Res. 2013, 1833, 2996.

[61] J. Jin, J. K. Byun, Y. K. Choi, K. G. Park, Exp. Mol. Med. 2023, 55, 706.

RIGHTS & PERMISSIONS

2025 The Author(s). Interdisciplinary Medicine published by Wiley-VCH GmbH on behalf of Nanfang Hospital, Southern Medical University.